Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy

OBJECTIVE: To investigate the cost effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes (ACS) in the Platelet Inhibition and Patient Outcomes (PLATO) study who were scheduled for non-invasive management. METHODS: A previously developed cost effectiveness model was...

Descripción completa

Detalles Bibliográficos
Autores principales: Janzon, M, James, S, Cannon, C P, Storey, R F, Mellström, C, Nicolau, J C, Wallentin, L, Henriksson, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Healthcare Delivery, Economics and Global Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316918/
https://www.ncbi.nlm.nih.gov/pubmed/25227704
http://dx.doi.org/10.1136/heartjnl-2014-305864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316918/
https://www.ncbi.nlm.nih.gov/pubmed/25227704
http://dx.doi.org/10.1136/heartjnl-2014-305864

Ejemplares similares